Chronic repetitive transcranial magnetic stimulation alters β- adrenergic and 5-HT2 receptor characteristics in rat brain

Brain Research

Volumn 816, Issue 1, 1999, Pages 78-83

  Ben Shachar, Dorit ^a   Gazawi, Haifa ^a   Riboyad Levin, Judith ^a   Klein, Ehud ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

adrenergic receptor; 5 HT2 receptor; Brain monoamine; Rat; rTMS

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; DOPAMINE; NORADRENALIN; SEROTONIN; SEROTONIN 2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; ELECTROCONVULSIVE THERAPY; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MOOD; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TRANSCRANIAL MAGNETIC STIMULATION;

ANIMALS; BIOGENIC MONOAMINES; BRAIN; CORPUS STRIATUM; DOPAMINE; ELECTROMAGNETIC FIELDS; FRONTAL LOBE; HIPPOCAMPUS; MALE; NOREPINEPHRINE; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, GABA-A; RECEPTORS, SEROTONIN; SEROTONIN; TIME FACTORS;

EID: 0033573685     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01119-6     Document Type: Article

References (43)

1. Artigas F., Perez V., Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry. 51:1994;248-251.
2. Aston-Jones G., Akaoka H., Charlety P., Chouvet G. Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J. Neurosci. 11:1991;760-769.
3. Aulakh C.S., Cohen R.M., Dauphin M.M., McLellan C.A., Murphy D.L. Role of serotonergic input in the down-regulation of β-adrenoceptors following long-term clorgyline treatment. J. Pharmacol. 156:1988;53-70.
4. Baker A.T. An introduction to the basic principles of magnetic nerve stimulation. J. Clin. Neurophysiol. 8:1991;26-37.
5. Baraban J.M., Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology. 19:1980;355.
6. Belmaker R.H., Grisaru N., Ben-Shachar D., Klein E. The effect of TMS on animal model of depression, β-adrenergic receptors and brain monoamines. CNS Spectrum. 2:1997;26-30.
7. Ben-Shachar D., Belmaker R.H., Grisaru N., Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. J. Neural Trans. 104:1997;191-197.
8. Ben-Shachar D., Klein E., Tabak A., Finberg J.P.M. Effect of single and repeated ministration of fluvoxamine on noradrenaline release in rat brain. Eur. J. Pharmacol. 332:1997;237-324.
9. Berstrom D.A., Kellar K.J. Effects of electroconvulsive shock on monoaminergic binding sites in rat brain. Nature. 278:1979;464-466.
10. Blandina P., Goldfarb J., Walcott J., Green J.P. Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices. J. Pharmacol. Exp. Ther. 256:1991;341-347.
11. Fleischmann A., Sternheim A., Etgen A.M., Li C., Grisaru N., Belmaker R.H. Transcranial magnetic stimulation down regulates beta-adrenoreceptors in rat cortex. Neural Transm. 103:1996;1361-1366.
12. Fozard J.R. Neuronal 5-HT receptors in the periphery. Neuropharmacology. 23:1984;1473-1486.
13. Gates J.R. Transcranial magnetic stimulation. Neuroimaging. Clin. N. Am. 5:1995;711-720.
14. George M.S., Wassermann E.M., Williams W.A., Callahan A., Ketter T.A., Basser P., Hallett M., Post R.M. Daily repetitive transcranial magnetic stimulation improves mood in depression. NeuroReport. 6:1995;1853-1856.
15. Glue P., Costello M.J., Pert A., Mele A., Nutt D.J. Regional neurotransmitter responses after acute and chronic electroconvulsive shock. Psychopharmacology. 100:1990;60-65.
16. Grisaru N., Yaroslavsky U., Abarbanel J., Lamberg T., Belmaker R.H. Transcranialmagnetic stimulation in depression and schizophrenia. Eur. Neuropsychopharmacol. 4:1994;287-288.
17. N. Grisaru, B. Chudakav, U. Yaroslavsky, R.H. Belmaker, TMS in mania: a controlled study, J. Psychiatry (1998) in press.
18. Halbreich U., Lumley L.A. The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J. Affect. Disord. 29:1993;159-173.
19. M. Hamon, Radioactive ligand binding studies: identification of central serotonin receptors, in: P.J. Marangos, I.C. Campbell, R.M. Cohen (Eds.), Brain Receptor Methodologies, Academic Press, New York, 1988, pp. 309-338.
20. Heal D.J., Butler S.A., Hurst E.M., Buckett W.R. Antidepressant treatments including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortex. J. Neurochem. 53:1989;1019-1025.
21. Helmeste D.M. Rapid down-regulation of S2 serotonin receptors by antidepressant: noradrenergic-serotonergic interactions. Life Sci. 39:1986;223-227.
22. Hosoda K., Duman R.S. Regulation of beta 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex. J. Neurochem. 60:1993;1335-1343.
23. 3H -ligand for serotonin 2 receptor binding site. Binding properties, brain distribution and functional role Mol. Pharmacol. 21:1982;301-304.
24. Maj J., Klimek V.J., Nowak G. Antidepressant drugs given repeatedly increase binding to alpha 1-adrenoceptors in the rat cortex. Eur. J. Pharmacol. 119:1985;113-116.
25. Mongeau R., de Montingy C., Blier P. Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alpha-2 adrenoceptors modulating serotonin neurotransmission. J. Pharmacol. Exp. Ther. 269:1994;1152-1159.
26. Owens M.J. Molecular and cellular mechanisms of antidepressant drugs. Depress Anxiety. 4:1996;153-159.
27. 2 and alpha 1-adrenoceptors and phosphoinositide signaling system in rat brain. Eur. J. Pharmacol. 226:1992;303-310.
28. Pascual-Leone A., Catala M.D., Pascual-Leone P.A. Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood. Neurology. 46:1996;499-502.
29. Pascual-Leone A., Rubio B., Pallardo F., Catala M.D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 348:1996;959.
30. Pickel V.M., Joh T.H., Reis D. A serotonergic innervation of noradrenergic neurons in locus coeruleus: demonstration by immunocytochemical localization of the transmitter specific enzymes tyrosine and tryptophan hydroxylase. Brain Res. 131:1977;197-214.
31. Plaznik A., Stfanski R., Palejko W., Bidzinski A., Kostowski W., Jessa M., Nazar M. Antidepressant treatment and limbic serotonergic mechanisms regulating rat locomotor activity. Pharmacol. Biochem. Behav. 48:1994;315-325.
32. Potter W.Z. Adrenoceptors and serotonin receptor function: relevance to antidepressant mechanism of action. J. Clin. Psychiatry. 57:1996;4-8. (Suppl. 4).
33. 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study. Eur. J. Pharmacol. 261:1994;59-65.
34. Salmon R.M., Miller H.L., Delgado P.L. The use of tryptophan depletion to evaluate central serotonin function in depression and other neuropsychiatric disorders. Int. Clin. Psychopatholpharmacol. Suppl. 2:1993;41-46.
35. Storm-Mathisen J. Localisation of transmitter candidates in the brain: the hippocampal formation as a model. Prog. Neurobiol. 8:1977;119-181.
36. Sulser F. Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders. J. Clin. Psychiatry. 48:1987;12-18. Suppl.
37. J.W. Thomas, J.F. Tallman, Solubilization and characterization of brain benzodiazepine binding sites, in: P.J., Marangos, I.C. Campbell, R.M. Cohen (Eds.), Brain Receptor Methodologies, Academic Press, New York, 1988, pp. 95-113.
38. Wei H.B., Niu X.Y. Comparison of the affinities of amoxapine and loxapine for various receptors in rat brain and the receptor down-regulation after chronic administration. Acta Pharmaceutica Sinica. 25:1990;881-885.
39. Yoshida K., Higuchi H., Kamata M., Shimiz T., Hishikawa Y. Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 21:1997;707-715.
40. Zis A.P., Nomikos G.G., Brown E.E., Damsma G., Fibiger H.C. Neurochemical effects of electrically and chemically induced seizures: an in vivo microdialysis study in the rat hippocampus. Neuropsychopharmacology. 7:1992;189-195.
41. Zyss T., Gorka Z., Kowalska M., Vetulani J. Preliminary comparison of behavioral and biochemical effects of chronic transcranial magnetic stimulation and electroconvulsive shock in the rat. Biol. Psychiatry. 42:1997;920-924.
42. Feinsod M., Kreinin B., Chistyakov A., Klein E. Preliminary evidence for a beneficial effect of low-frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia. Depression and Anxiety. 7:1998;65-68.
43. E. Klein, B. Kreinin, A. Chistyakov, D. Koren, L. Mecz, S. Marmur, D. Ben-Shachar, M. Teinsod, Therapeutic efficacy of right prefrontal slow-repetitive transcranial magnetic stimulation in major depression: a double blind controlled study, Arch. Gen. Psychiatry, 1998, in press.